Inhibikase Therapeutics Inc (IKT) Stock: Navigating a Year of Stock Volatility
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Inhibikase Therapeutics Inc’s current trading price is -14.14% away from its 52-week high, while its distance from the 52-week low is 310.98%.